Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Apr 19, 2019
Targets & Mechanisms
The next wave in neurodegeneration expands beyond neurons
...factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB; NFKB1; p105; p50)
ImStar Therapeutics Inc.
...
Read More
BioCentury
|
Oct 20, 2016
Finance
3Q16 Public-Private Partnership Roundup
...which is developing a test for rapid, early and accurate diagnosis of sepsis. June 2016
ImStar Therapeutics Inc.
...
Read More
BioCentury
|
Feb 18, 2016
Product R&D
Crossing paths
...fumarate Preclinical FPRT Bio Inc. / Xencor Inc. (NASDAQ:XNCR) XPro1595 Dominant-negative inhibitor of TNFα Preclinical
ImStar Therapeutics Inc.
...
Read More
BioCentury
|
Feb 3, 2014
Emerging Company Profile
ImStar: Neuronal pacifier
...Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd. , Yongin-si, South Korea
ImStar Therapeutics Inc.
...
...Palo Alto, Calif. Regenesance B.V. , Amsterdam, the Netherlands Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Sidebars
ImStar Therapeutics Inc.
...
Read More
Items per page:
10
1 - 4 of 4
BioCentury
|
Apr 19, 2019
Targets & Mechanisms
The next wave in neurodegeneration expands beyond neurons
...factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB; NFKB1; p105; p50)
ImStar Therapeutics Inc.
...
Read More
BioCentury
|
Oct 20, 2016
Finance
3Q16 Public-Private Partnership Roundup
...which is developing a test for rapid, early and accurate diagnosis of sepsis. June 2016
ImStar Therapeutics Inc.
...
Read More
BioCentury
|
Feb 18, 2016
Product R&D
Crossing paths
...fumarate Preclinical FPRT Bio Inc. / Xencor Inc. (NASDAQ:XNCR) XPro1595 Dominant-negative inhibitor of TNFα Preclinical
ImStar Therapeutics Inc.
...
Read More
BioCentury
|
Feb 3, 2014
Emerging Company Profile
ImStar: Neuronal pacifier
...Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd. , Yongin-si, South Korea
ImStar Therapeutics Inc.
...
...Palo Alto, Calif. Regenesance B.V. , Amsterdam, the Netherlands Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Sidebars
ImStar Therapeutics Inc.
...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page